Abbott's quarterly profit halves as costs soar
[BENGALURU] Diversified healthcare company Abbott Laboratories reported a 55 per cent drop in quarterly profit on Thursday, hurt by higher costs.
The company's net profit from continuing operations fell to US$270 million, or 15 US cents per share, in the second quarter ended June 30 from US$599 million, or 40 US cents per share, a year earlier.
Total operating cost and expenses surged 37.5 per cent to US$6.21 billion.
However, net sales rose to US$6.64 billion from US$5.33 billion.
Abbott, which closed its US$25 billion acquisition of St Jude Medical in January, agreed to buy troubled diagnostics company Alere Inc for a revised value of US$5.30 billion in April.
REUTERS
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Billionaire Geiger is said to near US$7 billion L’Occitane buyout
HCA beats first-quarter profit estimates on higher patient admissions
US FDA approves Pfizer’s gene therapy for rare bleeding disorder
EU toughens rules on Chinese fashion retailer Shein
Best World under fire from shareholders at AGM over dividends, director salaries
‘Extreme’ climate blamed for world’s worst wine harvest in 62 years